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Abstract 
Several new 4,5-dihydroimidazoles (and the corresponding imidazolium salts) carrying 
heteroatom substituents at C-2 have been prepared from the corresponding tetrahydroimidazol-2-
ones and/or -thiones.  
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Introduction 
 
As part of a programme to prepare optically active nitrogen heterocycles,1 we have reported on 
the use of 4,5-dihydroimidazolium ylides 2, available from the 4,5-dihydroimidazoles (2-
imidazolines) 1, in the assembly of pyrrolo[1,2-a]imidazoles (Scheme 1).2 Reductive removal of 
the templating atoms affords pyrrolidines.3 
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Scheme 1. Synthesis of optically active pyrrolidines from 4,5-dihydroimidazolium ylides. 
 
We proposed to extend this strategy to 2-heteroatom substituted 4,5-dihydroimidazoles 3 and 
their quaternary salts with the expectation that the corresponding cycloadducts 4 could lead to 
pyrrolidones on template removal (Scheme 2). Although this strategy was ultimately not fruitful, 
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we report here the preparation of new 2-thioalkyl, 2-alkoxy and 2-alkylamino 4,5-
dihydroimidazoles 3 and of the corresponding N-alkyl-4,5-dihydroimidazolium salts. 
Our first approach was to employ the chemistry of 1-benzyl-2-lithio-4,5-dihydroimidazole 
that we have reported,4 to generate 2-alkylthio or 2-arylthio derivatives.  
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Scheme 2. Proposed synthesis of pyrrolidones (ZRn = OR, SR, NR2). 
 
The sulfur substituent could also act as a leaving group to access O- and N-substituted 
compounds. When 1-benzyl-4,5-dihydroimidazole5 was deprotonated (BuLi, THF, –78°C) and 
reacted with diphenyl or dibutyl disulfides, the sulfur-substituted dihydroimidazoles 5a,b were 
isolated (Scheme 3), however the major product (40%) was 1-benzyl-tetrahydroimidazol-2-one 
6a, arising presumably from adventitious hydrolysis during isolation. 
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Scheme 3 
 
This prompted us to explore an alternative approach to 3 via this cyclic urea 6a and sulfur 
analogue 6b, which were readily available in good yield by reaction of N-benzyl-1,2-
diaminoethane with 1,1’-carbonyldiimidazole and 1,1’-thiocarbonyldiimidazole, respectively 
(Scheme 4). Attempts to O-alkylate urea 6a using Meerwein’s salts or methyl 
trifluoromethanesulfonate (MeOTf) were unproductive in our hands. In contrast, thiourea 6b was 
readily methylated on sulfur (MeI, heat; or MeOTf, 20°C) to provide the salt 7 that was 
neutralised (solid K2CO3) to give to the first of the targets 3, the 2-methylthio compound 8 
(86%). Salt 7 also proved useful in preparation of other 2-heteroatom substituted 4,5-
dihydroimidazoles. Thus treatment with sodium ethoxide (EtOH reflux, 24h) afforded the 2-
ethoxy derivative 9 (66%). The 2-amino compounds 10a,b were prepared using ethylamine 
(THF reflux, 20h; 75%) and pyrrolidine (reflux, 20h; 47%), respectively; no reaction was 
observed with the bulky tert-butylamine or the aromatic amine aniline. 
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Having a secure access to 2-heteroatom-substituted 4,5-dihydroimidazoles, we next targeted 
the corresponding 1-benzyl-3-alkoxycarbonylmethyl-4,5-dihydroimidazolium salts as direct 
precursors to 4,5-dihydroimidazolium ylides. Disappointingly, heating 2-methylthio compound 8 
with methyl bromoacetate (THF reflux, 5h) gave no reaction, and attempted alkylations with 
iodoacetonitrile or ethyl methanesulfonyloxyacetate were also fruitless. The 2-ethoxy 9 and 2-
amino-4,5-dihydroimidazoles 10 behaved similarly. We therefore decided to reverse the 
sequence of incorporation of C-2 and C-3 substituents. The cyclic urea 6a was converted into the 
N-methoxycarbonylmethyl compound 11a by deprotonation with sec-BuLi (THF, –78°C) and 
reaction with methyl bromoacetate (THF reflux, 24h; 41%) (Scheme 4); other bases proved less 
effective. Neither this method, nor Mitsunobu conditions using ethyl glycolates, were successful 
in the analogous reactions of thiourea 6b, and direct treatment of 6b with methyl bromoacetate 
(THF reflux, 18h) afforded the S-alkylation product 12 (87%). The N-alkylated thiourea 11b was 
however accessed by thionation of urea 11a with Lawesson’s reagent (o-xylene reflux, 26h; 
66%).6 
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Scheme 4 
 
In order to generate 4,5-dihydroimidazolium ylides from urea 11a and thiourea 11b, O- or S-
alkylation, respectively, was required. S-Methylation of 11b was accomplished with MeOTf to 
afford a salt 13 which displayed the expected NMR spectral characteristics but was not 
completely characterised. NMR spectroscopic evidence was likewise obtained for salts 14a-c 
prepared in an NMR tube from urea 11a using triethyloxonium tetrafluoroborate, 
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trifluoromethanesulfonic anhydride and tert-butyl-dimethylsilyl trifluoromethanesulfonate, 
respectively. Downfield shifts of product peaks were observed relative to the urea, although 
these putative salts proved too hygroscopic for further analysis. In any event, one-pot attempts by 
our usual protocol5 to induce formation of salts 13 or 14, deprotonation to an ylide and  
cycloaddition were unsuccessful. The major isolated product in each case was urea 11a, 
presumably from quaternary salt hydrolysis. 
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Figure 1. 4,5-Dihydroimidazolium salts observed spectroscopically. 
 
We prepared two alternative series of 1,3-disubstituted tetrahydroimidazolin-2-ones and 2-
thiones as potential ylide precursors. In the first of these, cyclic urea 6a was N-silylmethylated to 
give 15a (NaH, DMSO, Me3SiCH2Cl or Me3SiCH2I; 45%) (Scheme 5), with a view ultimately to 
ylide generation by desilylation.7 1-Benzyl-3-methyltetrahydroimidazol-2-one 16 was isolated as 
a by-product (27%). The thiourea 15b was prepared from 15a by thionation (Lawesson’s 
reagent, o-xylene reflux; 69%). As above, O-alkylation of 15a was attempted (NMR tube) with 
MeOTf or triethyloxonium tetrafluoroborate but proceeded only to partial conversion after 
several hours. Attempted one-pot alkylation, desilylation (CsF) and cycloaddition was 
unsurprisingly unsuccessful with 15a. With 15b, although salt 17 could be observed (NMR) 
using MeOTf as alkylating agent, the one-pot protocol returned unchanged thiourea 15b and urea 
15a, representing presumably incomplete S-alkylation and hydrolysis of S-alkyl salt 17. 
 
N
N
H
CH2Ph
O
6a
NaH, DMSO,
Me3SiCH2Cl/I
15a; X = O
15b; X = S
N
N
CH2Ph
X
CH2SiMe3
Lawesson reagent,
xylene reflux
16
N
N
CH2Ph
X
Me
N
N
CH2Ph
SMe
17
CH2SiMe3
TfO–
 
 
Scheme 5 
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The second alternative series of (thio)ureas comprised the 1,3-dibenzyl compounds 18a,b, 
readily available from commercial N,N’-dibenzyl-1,2-diaminoethane and carbonyl or 
thiocarbonyldiimidazole, respectively (18a 97%; 18b 98%) (Scheme 6). S-Methylation of 18b 
(MeOTf, CH2Cl2, 20°C) afforded salt 19 in quantitative yield. This salt provided access to 2-
imino compound 20 (MeNH2, THF reflux 18h; 40%). The salt 21 was observed 
spectroscopically from 19 and pyrrolidine, as were salts 22a-c from reaction of urea 18a with 
trifluoromethanesulfonic anhydride, trimethylsilyl trifluoromethane-sulfonate or tert-
butyldimethylsilyl trifluoromethanesulfonate, respectively. To test for benzylic deprotonation in 
this series, (thio)ureas 18a,b were treated with base (sec-BuLi, THF, -78°C) and quenched with 
CF3CO2D, when clean mono-deuteration was observed (PhCH2 signal, 4H at δ 4.41 and 4.92 
respectively, converted to two singlets 0.03 ppm apart, integrating as 2H and 1H). Similar 
treatment of the salt 22c afforded mono-deuteration. However, when the salts 19, 21 and 22a-c 
were subjected to the one-pot deprotonation-cycloaddition protocol5 with methylacrylate, no 
cycloadducts were observed. 
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Scheme 6 
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Figure 2. 4,5-Dihydroimidazolium salts observed spectroscopically. 
 
These studies, whilst not to date affording 1,3-dipolar cycloaddition, have generated some 
new 2-heteroatom substituted 4,5-dihydroimidazoles 3 via cyclic ureas, and explored generation 
of the corresponding imidazolium salts. 
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Experimental Section 
 
General Procedures. Proton (1H) and carbon (13C) NMR spectra were recorded in CDCl3 using 
either a JEOL EX400 (400 and 100MHz, respectively) or a JEOL LA300 spectrometer (300 and 
75MHz, respectively). Chemical shifts are reported in parts per million (ppm) from 
tetramethylsilane (TMS) as the internal standard. Multiplicities are given as: s-singlet, d-doublet, 
t-triplet, q-quartet, quin-quintet, sext-sextet, m-multiplet, br-broad signal. Coupling constants (J) 
are expressed in Hz. Infrared spectra were recorded using a Perkin-Elmer 1710 Fourier 
Transform infrared spectrophotometer. Low resolution mass spectra were recorded using a VG 
Micromass VG-250 mass spectrometer by electron impact (EI), chemical ionisation (CI) or fast 
atom bombardment (FAB) methods, the latter employing a thioglycerol matrix in both positive 
and negative ion modes. Accurate mass measurements were performed by the EPSRC National 
Mass Spectrometry Service (University of Wales, Swansea, UK). Elemental analyses were 
performed by MEDAC Ltd, Brunel Science Centre, Surrey, TW20 0JZ, UK. X-Ray 
crystallography was performed by the EPSRC X-Ray Crystallographic Service (University of 
Southampton, UK). Optical rotations were measured on a JASCO DIP-1000 digital polarimeter. 
Melting points were measured on a Kofler hot-stage apparatus and are uncorrected. Column 
chromatography was carried out using Fluka Silica Gel 60 (220-440mesh) (Brockmann 2-3). 
TLC analysis was carried out using Machery-Nagel Polygram SIL G/UV254 plates on a plastic 
backing and visualised by ultraviolet light or aqueous potassium permanganate spray 
(KMnO4:K2CO3:water, 6:1:100, w/w/v). 
All chemicals were purified by distillation or recrystallisation where appropriate. THF, THP, 
diethyl ether, toluene, ethanol and glyme were dried over sodium or potassium and distilled. 
DCM and DMSO were dried over sodium or calcium hydride and distilled. Anhydrous reactions 
were carried out using flamed dried glassware with all transfers performed using oven-dried 
syringes and needles. 
 
1-Benzyltetrahydroimidazol-2-one (6a). To N-benzyl-1,2-diaminoethane (5.00 g; 33.0 mmol) 
in dry THF (200 ml) under nitrogen was added a solution of 1,1′-carbonyldiimidazole (6.48 g; 
40.0 mmol) in dry THF (25 ml). The resulting solution was stirred at RT for 18 h. The solvent 
was removed under reduced pressure and the mixture was washed with dilute hydrochloric acid 
(2M; 50 ml) and extracted with dichloromethane (2 × 50 ml). The combined organic phases were 
dried (MgSO4) and the solvent removed under reduced pressure to afford the title compound 6a 
as a white crystalline solid (5.79 g; 99%): m.p. 124-127°C (lit.,8 127°C) (Found: (EI): M•+ 
176.0941; C10H12N2O requires M•+ 176.0949); νmax(nujol)/cm–1 1601, 1496, 1467, 1301 and 
1116; δH (400 MHz) 3.38 and 3.42 (each m, 2H, NCH2CH2N), 4.40 (s, 2H, CH2Ph), 7.29 (m, 5H, 
Ar-H); δC (100 MHz) 38.2 (CH2Ph) 44.5 and 47.7 (CH2N), 127.5, 128.1 and 128.6 (Ar-CH) 
136.9 (Ar-C), 162.8 (CO); m/z (EI) 176 (M•+, 100%), 161 (2), 147 (35), 132 (7), 104 (43), 99 
(28), 91 (91), 85 (27), 77(9), 65 (21), 56 (8). 
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1-Benzyltetrahydroimidazol-2-thione (6b). Prepared according to the method used to 
synthesize 6a, using N-benzyl-1,2-diaminoethane (0.50 g; 3.30 mmol) in dry THF (33 ml) and 
1,1′-thiocarbonyl-diimidazole (0.71 g; 3.99 mmol) in dry THF (5 ml) to afford the title 
compound 6b as a white crystalline solid (0.60 g; 94%): m.p. 181-182°C (lit.,9 177-182°C) 
(Found: (FAB): M•+ 192.0711; C10H12N2S requires M•+ 192.0721); υmax(nujol)/cm–1 3401, 2924, 
1556, 1377, and 722; δH (400 MHz) 3.60 (s, 4H, NCH2CH2N) 4.84 (s, 2H, CH2Ph), 7.38 (m, 5H, 
Ar-H); δC (100 MHz) 41.3 (CH2Ph) 48.0 and 51.0 (CH2N), 127.8, 128.2 and 128.7 (Ar-CH), 
135.1 (Ar-C), 183.2 (CS); m/z (EI) 192 (M•+, 55%), 176 (2), 131 (10), 104 (20), 91 (100), 89 (7), 
77 (13), 68 (37), 65 (32), 56 (12). 
1-Benzyl-2-methylthio-4,5-dihydroimidazole (8). Iodomethane (32.0 ml; 50.0 mmol) was 
added to 1-benzyltetrahydroimidazol-2-thione 6b (2.03 g; 10 mmol) and the mixture heated at 
reflux for 16 h under nitrogen. After allowing the mixture to cool to RT the excess MeI was 
removed under reduced pressure and the residue evaporated twice from dry methanol (2 × 10 ml) 
to afford the imidazolium salt 7 as a yellow solid (1.89 g, 87%): m.p. 102-105°C; δH (400 MHz) 
2.68 (s, 3H, SCH3), 4.04 and 4.10 (each t, 2H, J = 9.2, NCH2CH2N), 4.60 (s, 2H, CH2Ph), 7.33 
(m, 5H, Ar-H); δC (100 MHz) 16.2 (SCH3), 51.9 (CH2Ph), 53.3 and 53.8 (CH2N), 127.6, 128.3 
and 128.7 (Ar-CH), 137.4 (Ar-C), 164.1 (NCS). The salt 7 (1.88 g; 5.6 mmol) in 
dichloromethane (50 ml) was treated with excess K2CO3 (7.7 g) and the resulting solution stirred 
at RT for 1 h. The solution was filtered, extracted with dichloromethane (2 × 50 ml) and the 
combined organic phases dried (MgSO4). The solvent was removed under reduced pressure to 
afford the title compound 8 as a yellow solid (1.61 g, 86%) (Found: (FAB): M•+ 206.0875; 
C11H14N2S requires M•+ 206.0877): m.p. 95-98°C; υmax(nujol)/cm–1 3128, 1587, 1563, 1497, 738 
and 723; δH (400 MHz) 2.68 (s, 3H, SCH3), 3.83 and 3.98 (each t, 2H, J = 9.2, NCH2CH2N), 
4.37 (s, 2H, CH2Ph), 7.28 (m, 5H, Ar-H); δC (100 MHz) 14.6 (SCH3), 50.89 (CH2Ph), 51.28 and 
51.42 (CH2N), 127.8, 128.2 and 128.8 (Ar-CH), 136.2 (Ar-C), 163.8 (NCS); m/z (EI) 206 (M•+, 
10%), 191 (17), 116 (5), 91 (34), 28 (100). 
1-Benzyl-2-ethoxy-4,5-dihydroimidazole (9). A freshly prepared solution of NaOEt (0.38 g; 
5.7 mmol) in EtOH (20 ml) was added to 1-benzyl-2-methylthio-4,5-dihydroimidazolium iodide 
7 (0.46 g; 2.3 mmol) and the resulting solution heated at reflux for 24 h. Water (10 ml) was 
added and the solution extracted with dichloromethane (2 × 50 ml). The combined organic 
phases were dried (MgSO4), filtered and evaporated under reduced pressure to afford the title 
compound 9 as a white solid (0.30 g; 66%): m.p. 162-165°C (Found: (FAB): M•+ 204.1264; 
C12H16N2O requires M•+ 204.1262); δΗ (400 MHz) 1.20 (t, 3H, J = 5.2, OCH2CH3) 3.15 and 3.32 
(each t, 2H, J = 6.6, NCH2CH2N), 4.14 (s, 2H, CH2Ph), 4.19 (q, 2H, J = 5.2, OCH2CH3), 7.14 
(m, 5H, Ar-H); δC (100 MHz) 14.62 (CH3), 38.02 (CH2Ph), 48.32 and 49.75 (CH2N), 65.11 
(OCH2), 127.3, 128.1 and 128.6 (Ar-CH), 137.6 (Ar-C), 164.0 (NCO); m/z (EI) 204 (M•+, 18%), 
176 (71), 159 (4), 91 (100), 77 (5), 85 (24), 65 (19), 56 (11). 
1-Benzyl-2-ethylamino-4,5-dihydroimidazole (10a). Ethylamine in THF (2M; 1.57 ml, 
3.15 mmol) was added to 1-benzyl-2-methylthio-4,5-dihydroimidazolium iodide 7 (0.45 g, 
2.1 mmol) in dry THF (20 ml) heated at reflux, and the resulting solution heated at reflux for a 
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further 20 h. The cooled solution was washed with aq. NaOH (0.1 M; 50 ml) and extracted with 
diethyl ether (2 × 50 ml). The organic phase was dried (MgSO4), filtered and the remaining 
solvent evaporated under reduced pressure. The residue was then purified by silica gel column 
chromatography using 2-propylamine/chloroform (1:99 v/v) as eluant to yield the title compound 
10a as a yellow gum (0.40 g, 75%) (Found: (EI) MH+ 204.1425; C12H17N3 requires MH+ 
204.1422): νmax(film)/cm–1 3320, 2980, 1440, 1265; δH (400 MHz) 1.40 (t, 3H, J = 5.7, 
NHCH2CH3), 3.62 (m, 4H, NCH2CH2N and NHCH2CH3), 3.76 (t, 2H, J = 6.9, NCH2CH2N), 
4.79 (s, 2H, CH2Ph), 7.38 (m, 5H, Ar-H); δC (100 MHz) 15.02 (CH3) 39.27 (CH2CH3), 47.42 and 
49.83 (CH2N), 128.3, 128.6 and 129.1 (Ar-CH), 133.5 (Ar-C), 157.5 (NCN). 
1-Benzyl-2-(pyrrolidin-1yl)-4,5-dihydroimidazole (10b). Pyrrolidine (0.20 ml; 2.0 mmol) was 
added to 1-benzyl-2-methylthio-4,5-dihydroimidazolium iodide 7 (0.42 g; 2.0 mmol) in dry THF 
(20 ml) heated at reflux, and the solution heated at reflux for a further 20 h. The solution was 
allowed to cool to RT, washed with aq. NaOH (0.1 M; 2 × 10 ml) and extracted with diethyl 
ether (2 × 50 ml). The combined organic layers were washed with water and the water layers 
extracted with diethyl ether (2 × 50 ml). The combined organic layers were dried (MgSO4), 
filtered and evaporated under reduced pressure. The residue was purified by silica gel column 
chromatography using 2-propyl-amine/chloroform (1:99 v/v) as eluant to afford the title 
compound 10b as a yellow liquid (0.22 g; 47%) (Found: (EI): M•+ 229.1566; C14H19N3 requires 
M•+ 229.1578): νmax(film)/cm–1 2984, 1487, 1226; δH (400 MHz) 1.89 (m, 4H, 
NCH2CH2CH2CH2N), 3.40 (m, 2H, NCH2CH2N), 3.42 (m, 4H, NCH2CH2CH2CH2N), 3.72 (t, 
2H, J = 6.8, NCH2CH2N), 4.34 (s, 2H, CH2Ph), 7.28 (m, 5H, Ar-H); δC (100 MHz) 25.5 
(NCH2CH2), 49.4 (CH2N), 50.6 (CH2Ph), 52.9 and 54.2 (CH2N), 126.9, 127.1 and 128.6 (Ar-
CH), 138.5 (Ar-C), 164.6 (NCN); m/z (EI) 229 (M•+, 54%), 200 (41), 186 (36), 159 (61), 138 
(22), 125 (37), 110 (23), 91 (100), 82 (36), 70 (53), 65 (30), 55 (55), 41 (28), 28 (37). 
1-Benzyl-3-methoxycarbonylmethyltetrahydroimidazol-2-one (11a). To 1-benzyltetrahydro-
imidazol-2-one 6a (1.03 g; 5.85 mmol) in dry THF (25 ml) under nitrogen at –78°C was added 
dropwise a solution of sec-BuLi (2.5M in hexanes; 7.02 mmol). The mixture was left at –78°C 
for 10 min and methyl bromoacetate (5.40 ml; 7.02 mmol) was then added dropwise. The 
mixture was heated at reflux for 24 h and then allowed to cool to RT. The solvent was removed 
under reduced pressure and the residue purified by silica gel column chromatography using ethyl 
acetate/hexane (4:6 v/v) as eluant to afford the title compound 11a as colourless oil (0.60 g; 
41%) (Found: (EI): M•+ 248.1157; C13H16N2O3 requires M•+ 248.1161): νmax(film)/cm–1 2952, 
2872, 1748, 1700, 1400, 1495, 1449, 1361, 1264, 1214, 986, 937, 760, 703; δH (300 MHz) 3.25 
and 3.44 (each t, 2H, J = 10.6, NCH2CH2N), 3.75 (s, 3H, CO2CH3), 4.03 (s, 2H, CH2CO2CH3), 
4.40 (s, 2H, CH2Ph), 7.33 (m, 5H, Ar-H); δC (75 MHz) 42.0 (CH2), 43.0 (CH3), 45.6 (CH2), 48.2 
and 52.0 (CH2N), 127.4, 128.1 and 128.6 (Ar-CH), 137.0 (Ar-C), 163.0 (NCO), 170.1 (CO); m/z 
(EI) 248 (M•+, 12%), 189 (22), 175 (5), 92 (8), 91 (100), 65 (9), 42 (9). 
1-Benzyl-3-methoxycarbonylmethyltetrahydroimidazol-2-thione (11b). To 1-benzyl-3-
methoxy-carbonylmethyltetrahydroimidazol-2-one 11a (0.20 g; 0.75 mmol) in dry ortho-xylene 
(30 ml) was added portionwise Lawesson’s Reagent ([2,4-bis(4-methoxyphenyl)]-1,3-dithia-2,4-
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diphosphetane-2,4-disulfide) (0.30 g; 0.75 mmol). The mixture heated at reflux for 26 h after 
which time it was allowed to cool to RT. The solvent was removed under reduced pressure and 
the residue purified by silica gel column chromatography using ethyl acetate/hexane (4:6 v/v) as 
eluant to yield the title compound 11b as yellow gum (0.14 g; 66%) (Found: (EI): M•+ 264.0931; 
C13H16N2O2S requires M•+ 264.0932): νmax(film)/cm–1 2950, 2874, 1742, 1404, 1497, 1449, 
1266, 1211, 983, 762; δH (300 MHz) 3.45 and 3.64 (each t, 2H, J = 10.7, NCH2CH2N), 3.77 (s, 
3H, CO2CH3), 4.44 (s, 2H, CH2CO2CH3), 4.91 (s, 2H, CH2Ph), 7.35 (m, 5H, Ar-H); δC (75 
MHz)45.6 (CH2), 46.4 (CH3), 48.8 (CH2), 51.8 and 52.2 (CH2N), 127.7, 128.1 and 128.7 (Ar-
CH), 138.2 (Ar-C), 170.0 (CO), 183.6 (NCS); m/z (EI) 264 (M•+, 40%), 205 (22), 191 (8), 141 
(10), 102 (8), 91 (100), 72 (16), 65 (14), 42 (13), 28 (27). 
1-Benzyl-2-methoxycarbonylmethylthio-4,5-dihydroimidazole (12). To 1-benzyltetrahydro-
imidazol-2-thione 6b (0.30 g; 1.56 mmol) in dry THF (25 ml) under nitrogen was added methyl 
bromoacetate (0.13 ml; 1.87 mmol) and the resulting solution was heated at reflux for 18 h and 
then allowed to cool to RT. The solvent was evaporated under reduced pressure and the residue 
purified by silica gel column chromatography using ethyl acetate/hexane (45:55 v/v) as eluant to 
afford the title compound 12 as a white solid (0.36 g; 87%): m.p. 111-112°C (Found: (EI) MH+ 
265.1014; C13H16N2O2S requires MH+ 265.1010); νmax(nujol)/cm–1 2952, 2865, 1740, 1410, 
1264; δH (300 MHz) 3.74 (s, 3H, CO2CH3), 3.81 and 3.94 (each m, 2H, NCH2CH2N), 4.59 (s, 
2H, SCH2CO2CH3), 4.70 (s, 2H, CH2Ph), 7.32 (m, 5H, Ar-H); δC (75 MHz) 35.6 (CH2), 44.0 
(CO2CH3), 49.6 (SCH2), 51.3 and 53.6 (CH2N), 128.0, 128.8 and 129.3 (Ar-CH), 132.3 (Ar-C), 
168.4 (CO); m/z (EI) 265 (MH+, 44%), 192 (100), 159 (10), 104 (18), 91 (50). 
1-Benzyl-3-methoxycarbonylmethyl-2-methylthio-4,5-dihydroimidazolium trifluoromethane-
sulfonate (13). To 1-benzyl-3-methoxycarbonylmethyltetrahydroimidazol-2-thione 11b (0.30 g; 
1.10 mmol) in dry dichloromethane (10 ml) under a nitrogen atmosphere was added neat MeOTf 
(0.15 ml; 1.36 mmol) and the solution allowed to stir at RT for 1 h. The solvent was removed 
under reduced pressure to yield the title compound 13 as a yellow gum that was partially 
characterised (0.46 g; 97%); δH (300 MHz) 2.78 (s, 3H, SCH3), 3.71 and 3.82 (each t, 2H, J = 
10.4, NCH2CH2N), 3.75 (s, 3H, CO2CH3), 4.54 (s, 2H, CH2CO2CH3), 5.03 (s, 2H, CH2Ph), 7.46 
(m, 5H, Ar-H); δC (75 MHz) 17.2 (SCH3), 47.1 (CH2), 46.9 (CO2CH3), 49.2 (CH2), 53.1 and 53.6 
(CH2N), 127.8, 128.4 and 128.8 (Ar-CH), 140.2 (Ar-C), 171.7 (CO), 185.1 (NCS). 
1-Benzyl-3-trimethylsilylmethyltetrahydroimidazol-2-one (15a). To a suspension of NaH 
(0.19 g; 8.29 mmol) in dry DMSO (25 ml) was added dropwise a solution of 1-benzyl-4,5-
dihydroimidazol-2-one 6a (1.46 g; 8.29 mmol) in dry DMSO (25 ml) at RT. The mixture was 
stirred for 30 min and then chloromethyltrimethylsilane (2.24 ml; 12.43 mmol) was added. The 
resulting mixture was stirred at RT for 10 h, filtered, and the solvent removed under reduced 
pressure. The residue was purified by column chromatography on silica gel using ethyl 
acetate/hexane (4:6 v/v) as eluant to afford the title compound 15a as colourless oil (0.99 g; 
45%) (Found: (EI): M•+ 262.1503; C14H22N2OSi requires M•+ 262.1501): νmax(film)/cm–1 3030, 
2952, 2860, 1696, 1444, 1359, 1251, 856, 756; δH (300 MHz) 0.31 (s, 9H, Si(CH3)3), 2.54 (s, 
2H, CH2Si), 3.25 and 3.41 (each m, 2H, NCH2CH2N), 4.51 (s, 2H, CH2Ph), 7.36 (m, 5H, Ar-H); 
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δC (75 MHz) –1.6 (SiCH3), 35.4 and 42.5 (CH2), 45.5 and 48.7 (CH2N), 127.2, 128.1 and 128.5 
(Ar-CH), 137.5 (Ar-C), 161.8 (NCO); m/z (EI) 262 (M•+, 12%), 248 (5), 247 (18), 189 (4), 171 
(8), 155 (7), 100 (9), 91 (100), 73 (77), 65 (16), 45 (22), 43 (13). Also isolated was 1-benzyl-3-
methyl-tetrahydroimidazol-2-one 16 as a colourless oil (0.44 g; 27%) (Found: (EI) M•+ 
190.1107; C11H14N2O requires M•+ 190.1106); δH (300 MHz) 2.82 (s, 3H, CH3), 3.13 and 3.18 
(each m, 2H, NCH2CH2N), 4.37 (s, 2H, CH2Ph); δC (75 MHz) 31.4 (CH3), 42.2 (CH2Ph), 44.9 
and 48.7 (CH2N), 127.4, 127.7 and 128.5 (Ar-CH), 137.3 (Ar-C), 161.5 (NCO); m/z (EI) 190 
(M•+, 30%), 161 (6), 113 (13), 99 (34), 92 (9), 91 (100), 89 (11), 77 (23), 65 (34), 56 (18), 51 
(16), 43 (13), 42 (44), 39 (15). 
1-Benzyl-3-trimethylsilylmethyltetrahydroimidazol-2-thione (15b). To 1-benzyl-3-trimethyl-
silylmethyltetrahydroimidazol-2-one 15a (0.86g; 3.28 mmol) in dry ortho-xylene (30 ml) was 
added portionwise Lawesson’s reagent (1.32g; 3.28 mmol). The mixture was heated at reflux for 
26 h after which time it was allowed to cool to RT. The solvent was removed under reduced 
pressure and the residue purified by column chromatography on silica gel using ethyl 
acetate/hexane (25:75 v/v) as eluant to afford the title compound 15b as a yellow gum (0.63 g; 
69%) (Found: (EI): M•+ 278.1287; C14H22N2SSi requires M•+ 278.1273): νmax(film)/cm–1 3030, 
2938, 1696, 1498, 1445, 1404, 1252, 1056, 760, 702; δH (300 MHz) 0.20 (s, 9H, Si(CH3)3), 3.12 
(s, 2H, CH2Si), 3.21 and 3.25 (each m, 2H, NCH2CH2N), 4.92 (s, 2H, CH2Ph), 7.32 (m, 5H, Ar-
H); δC (75 MHz) –1.4 (SiCH3), 39.3 and 45.3 (CH2), 48.5 and 52.1 (CH2N), 127.5, 128.1 and 
128.6 (Ar-CH), 136.8 (Ar-C), 182.9 (NCS); m/z (EI) 278 (M•+, 10%), 264 (5), 263 (21), 92 (8), 
91 (100), 73 (69), 65 (20), 45 (23). 
1-Benzyl-3-trimethylsilylmethyl-2-methylthio-4,5-tetrahydroimidazolium trifluoromethane 
-sulfonate (17). To 1-benzyl-3-trimethylsilylmethyl-4,5-tetrahydroimidazol-2-thione 15b 
(0.10 g; 0.36 mmol) in dry dichloromethane (10 ml) under a nitrogen atmosphere was added 
MeOTf (0.02 ml; 0.43 mmol) and the solution allowed to stir at RT for 1 h. The solvent was 
removed under reduced pressure to yield the title compound as a yellow gum that was partially 
characterised (0.15 g; 94%): δH (300 MHz) 2.49 (s, 3H, SCH3), 3.14 (s, 2H, CH2Si), 3.72 and 
3.76 (each m, 2H, NCH2CH2N), 4.64 (s, 2H, PhCH2), 7.24 (m, 5H, Ar-H); δC (75 MHz) –1.1 
(SiCH3), 17.3 (SCH3), 44.2 and 49.1 (CH2), 54.2 and 55.6 (CH2N), 127.4, 128.3 and 128.6 (Ar-
CH), 137.7 (Ar-C). 
1,3-Dibenzyltetrahydroimidazol-2-one (18a). To commercial N,N′-dibenzyl-1,2-
diaminoethane (0.40 g; 1.67 mmol) in dry THF (20 ml) under nitrogen was added 1,1′-
carbonyldiimidazole (0.38 g; 2.35 mmol) in dry THF (10 ml). The resulting solution was stirred 
at RT for 18 h before the solvent was evaporated under reduced pressure. The residue was 
washed with aq. HCl (2M; 50 ml) and extracted with dichloromethane (2 × 50 ml). The 
combined organic phases were dried (MgSO4), filtered and the solvent evaporated under reduced 
pressure to afford the title compound 18a as a white solid (0.41 g; 97%): m.p. 90-91°C (lit.,10 93-
94°C) (Found: (EI): M•+ 266.1414; C17H18N2O requires M•+ 266.1419); νmax(nujol)/cm–1 2927, 
2855, 1689, 1494, 1455, 1365, 1257, 711; δH (300 MHz) 3.16 (s, 4H, NCH2CH2N), 4.41 (s, 4H, 
2 × CH2Ph), 7.32 (m, 10H, Ar-H); δC (75 MHz) 42.2 (PhCH2), 48.6 (NCH2), 127.5, 128.3 and 
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128.6 (Ar-CH), 137.4 (Ar-C), 161.1 (NCO); m/z (EI) 266 (M•+, 73%), 189 (4), 175 (71), 132 (9), 
118 (6), 105 (8), 91 (100), 65 (15). 
1,3-Dibenzyltetrahydroimidazol-2-thione (18b). Prepared according to the method used to 
synthesize 18a, using N,N′-dibenzyl-1,2-diaminoethane (0.40 g; 1.67 mmol) and 1,1′-
thiocarbonyldiimidazole (0.38 g; 2.13 mmol) to afford the title compound 18b as a yellow solid 
(0.44 g; 98%): m.p. 87-92°C (lit.,11 90°C) (Found: (EI): M•+ 282.1188; C17H18N2S requires M•+ 
282.1191); νmax(nujol)/cm–1 2927, 2855, 1494, 1462, 1378, 1359, 1334, 1268, 1240, 731; δH 
(400 MHz) 3.40 (s, 4H, NCH2CH2N) 4.92 (s, 4H, 2 × CH2Ph), 7.38 (m, 10H, Ar-H); δC (100 
MHz) 45.7 (PhCH2), 52.1 (NCH2), 128.0, 128.5 and 129.0 (Ar-CH) 136.7 (Ar-C), 184.8 (NCS); 
m/z (EI) 282 (M•+, 20%), 191 (30), 105 (9), 91 (100), 65 (16), 56 (5). 
1,3-Dibenzyl-2-methylthio-4,5-dihydroimidazolium trifluoromethanesulfonate (19). Via a 
syringe was added dropwise MeOTf (0.09 ml; 0.85 mmol) to 1,3-dibenzyltetrahydroimidazol-2-
thione 18b (0.20 g; 0.71 mmol) in dry dichloromethane (10 ml). The solution was stirred at RT 
for 1 h and the solvent removed under reduced pressure to afford the title compound 19 as a 
yellow oil (0.32 g; 100%) (Found: (ES, M–CF3SO3): M•+ 297.1422; C18H21F3N2O3S2 requires 
(M–CF3SO3)•+ 297.1425): νmax(film)/cm–1 3034, 2944, 1591, 1574, 1499, 1455, 1357, 1262 (br), 
1225 (br), 1157 (br), 1031; δH (300 MHz) 2.86 (s, 3H, SCH3), 3.90 (s, 4H, NCH2CH2N), 4.92 (s, 
4H, 2 × CH2Ph), 7.29 (m, 6H, Ar-H), 7.37 (m, 4H, Ar-H); δC (75 MHz) 16.5 (SCH3), 47.8 
(CH2Ph), 53.3 (NCH2), 127.6, 127.9 and 128.5 (Ar-CH), 132.4 (Ar-C), 167.2 (NCS). 
1,3-Dibenzyl-2-methyliminotetrahydroimidazole (20). 2-Methylthio-4,5-dihydroimidazolium 
salt 19 was prepared as above from MeOTf (0.13 ml; 1.10 mmol) and 1,3-
dibenzyltetrahydroimidazol-2-thione 18b (0.26 g; 0.92 mmol) and after stirring at RT for 1 h 
methylamine (2M solution in THF; 0.69 ml; 1.38 mmol) was added and the resulting solution 
heated at reflux for 18 h. The solvent was removed under reduced pressure and the residue 
purified by column chromatography on silica gel eluting with 2-propylamine/chloroform (2:98 
v/v) to afford the title compound 20 as a yellow gum (0.10 g; 40%) (Found: (EI): MH+ 280.1738; 
C17H21N3 requires MH+ 280.1735): δH (300 MHz) 3.01 (s, 3H, NCH3), 3.44 (s, 4H, NCH2CH2N), 
4.53 (s, 4H, 2 × CH2Ph), 7.26 (m, 6H, Ar-H), 7.30 (m, 4H, Ar-H); δC (75 MHz) 30.9 (NCH3), 
46.7 (CH2Ph), 50.7 (NCH2), 127.5, 128.4 and 129.1 (Ar-CH), 133.8 (Ar-C), 158.5 (NCN); m/z 
(EI) 279 (M•+, 24%), 250 (10), 207 (16), 125 (19), 111 (35), 97 (58), 91 (23), 83 (57), 69 (77), 57 
(100), 49 (27), 43 (76), 39 (15), 29 (26). 
1,3-Dibenzyl-2-(tetramethyleneimino)tetrahydroimidazolinium trifluoromethane sulfonate 
(21). 2-Methylthio-4,5-dihydroimidazolium salt 19 was prepared as above from MeOTf 
(0.12 ml; 1.10 mmol) and 1,3-dibenzyltetrahydroimidazol-2-thione 18b (0.25 g; 0.88 mmol). 
After stirring at RT for 1 h the solvent was removed under reduced pressure, dry THF (25 ml) 
and pyrrolidine (0.09 ml; 1.0 mmol) were added to the residue under nitrogen and the solution 
was heated at reflux for 26 h. The solvent was removed under reduced pressure to afford the title 
compound 21 as a brown oil that was partially characterised (0.32 g; 77%): δH (300 MHz) 1.86 
(t, 4H, J = 6.6, NCH2CH2CH2CH2N), 3.61 (t, 4H, J = 6.6, NCH2CH2CH2CH2N), 3.84 (s, 4H, 
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NCH2CH2N), 4.76 (s, 4H, 2 × CH2Ph), 7.26 (m, 6H, Ar-H), 7.39 (m, 4H, Ar-H); δC (75 MHz) 
25.5, 49.4, 50.8 and 53.4 (CH2), 126.3, 128.2 and 129.3 (Ar-CH), 134.8 (Ar-C), 162.4 (NCN). 
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